| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Ibuprofen sodium |
布洛芬钠 |
31121-93-4 |
详细
|
| Pamicogrel |
101001-34-7 |
101001-34-7 |
详细
|
| JNJ-38877605 |
6-[二氟[6-(1-甲基-1H-吡唑-4-基)-1,2,4-噻唑并[4,3-B]吡嗪-3-基]甲基]-喹啉 |
943540-75-8 |
详细
|
| BCX 1470 methanesulfonate |
2-(氨基亚氨基甲基)苯并[B]噻吩-6-基 2-噻吩羧酸酯甲磺酸盐 (1:1) |
217099-44-0 |
详细
|
| Foretinib |
N-[3-氟-4-[[6-甲氧基-7-[[3-(吗啉-4-基)丙基]氧]喹啉-4-基]氧]苯基]-N'-(4-氟苯基)环丙烷-1,1-二甲酰胺 |
849217-64-7 |
详细
|
| BMS-794833 |
BMS-794833 |
1174046-72-0 |
详细
|
| CMX001 |
BRINCIDOFOVIR |
444805-28-1 |
详细
|
| Masitinib mesylate |
马赛替尼 |
1048007-93-7 |
详细
|
| Savolitinib |
沃利替尼 |
1313725-88-0 |
详细
|
| Sitravatinib |
CS-2638 |
1123837-84-2 |
详细
|
| Imrecoxib |
艾瑞昔布 |
395683-14-4 |
详细
|
| Oxidopamine hydrochloride |
6-羟基多巴胺盐酸盐 |
28094-15-7 |
详细
|
| Valganciclovir (hydrochloride) |
缬更昔洛韦盐酸盐 |
175865-59-5 |
详细
|
| Factor D inhibitor 6 |
Factor D inhibitor 6 |
1386455-51-1 |
详细
|
| Golvatinib |
N-[2-氟-4-[[2-[[[4-(4-甲基哌嗪-1-基)哌啶-1-基]羰基]氨基]吡啶-4-基]氧基]苯基]-N'-(4-氟苯基)环丙烷-1,1-二甲酰胺 |
928037-13-2 |
详细
|
| Mycro 3 |
944547-46-0 |
944547-46-0 |
详细
|
| sAJM589 |
SAJM589 |
2089-82-9 |
详细
|
| Diclofenac-d4 |
双氯芬酸D4 |
153466-65-0 |
详细
|
| POT-4 |
AC-ILE-CYS-VAL-TRP(ME)-GLN-ASP-TRP-GLY-ALA-HIS-ARG-CYS-THR-NH2 |
934461-40-2 |
详细
|
| VPC-70619 |
化合物 VPC-70619 |
2361742-30-3 |
详细
|
| B220 |
112228-65-6 |
112228-65-6 |
详细
|
| Nitroflurbiprofen |
158836-71-6 |
158836-71-6 |
详细
|
| Nebicapone |
NEBICAPONE |
274925-86-9 |
详细
|
| Ningetinib Tosylate |
对甲苯磺酸宁格替尼 |
1394820-77-9 |
详细
|
| Iptacopan |
LNP023 |
1644670-37-0 |
详细
|
| Pamufetinib mesylate |
TAS-115 MESYLATE |
1688673-09-7 |
详细
|
| Complement C5-IN-1 |
COMPOUND C5-IN-1 (COMPOUND 7) |
2365402-67-9 |
详细
|
| MYCi361 |
MYCI361 |
2289690-31-7 |
详细
|
| Onartuzumab |
ONARTUZUMAB ( 奥那妥组单抗 ) |
1133766-06-9 |
详细
|
| ComplementfactorD-IN-2 |
2-Azabicyclo[3.1.0]hexane-3-carboxamide, 2-[2-[3-acetyl-5-(2-methyl-5-pyrimidinyl)-1H-indazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-, (1R,3S,5R)- |
1903742-34-6 |
详细
|
| Vedaprofen |
维达洛芬, |
71109-09-6 |
详细
|
| Gemnelatinib |
|
2225123-30-6 |
详细
|
| Tenidap |
替尼达普 |
120210-48-2 |
详细
|
| SYN1143 |
N-[3-氟-4-[(7-甲氧基喹啉-4-基)氧基]苯基]-1-(2-羟基-2-甲基丙基)-5-甲基-3-氧代-2-苯基-2,3-二氢-1H-吡唑-4-甲酰胺 |
913376-84-8 |
详细
|
| GW-406381 |
GW-406381 |
221148-46-5 |
详细
|
| Etodolac |
依托度酸 |
41340-25-4 |
详细
|
| Stauprimide |
硫磺酰亚胺 |
154589-96-5 |
详细
|
| SCR-1481B1 |
麦他替尼胺丁三醇 |
1174161-86-4 |
详细
|
| FR-188582 |
189699-82-9 |
189699-82-9 |
详细
|
| Flurbiprofen-d5 |
FLURBIPROFEN-D5 |
215175-76-1 |
详细
|
| IRES-C11 |
|
342416-30-2 |
详细
|
| AMG-208 |
AMG 208 |
1002304-34-8 |
详细
|
| AC710 |
N-[4-[[[[5-(叔丁基)-3-异恶唑基]氨基]羰基]氨基]苯基]-5-[(1-乙基-2,2,6,6-四甲基-4-哌啶基)氧基]-2-吡啶甲酰胺 |
1351522-04-7 |
详细
|
| Ibuprofen-d3 |
氘代布洛芬 |
121662-14-4 |
详细
|
| KJ Pyr 9 |
KJ PYR 9 |
581073-80-5 |
详细
|
| BAY-474 |
化合物BAY-474 |
1033767-86-0 |
详细
|
| Rilotumumab |
RILOTUMUMAB ( 利妥木单抗 ) |
872514-65-3 |
详细
|
| Tiaprofenic acid |
噻洛芬酸 |
33005-95-7 |
详细
|
| Salicylic acid-d6 |
邻羟基苯甲酸-D6 |
285979-87-5 |
详细
|
| BMS 777607 |
N-[4-[(2-氨基-3-氯吡啶-4-基)氧基]-3-氟苯基]-4-乙氧基-1-(4-氟苯基)-2-氧代-1,2-二氢吡啶-3-甲酰胺 |
1025720-94-8 |
详细
|
| MK-8033 hydrochloride |
3-(1-甲基-1H-吡唑-4-基)-5-氧代-N-(2-吡啶基甲基)-5H-苯并[4,5]环庚三烯并[1,2-B]吡啶-7-甲烷磺酰胺盐酸盐 |
1283000-43-0 |
详细
|
| Iptacopan hydrochloride |
化合物LNP023 HYDROCHLORIDE |
1646321-63-2 |
详细
|
| Ripretinib |
瑞普替尼 |
1442472-39-0 |
详细
|
| KSI-3716 |
KSI-3716 |
1151813-61-4 |
详细
|
| Celecoxib-d7 |
塞来昔布-D7 |
544686-21-7 |
详细
|
| Terevalefim |
ANG-3777 |
1070881-42-3 |
详细
|
| Sudoxicam |
sudoxicam |
34042-85-8 |
详细
|
| Fosgonimeton |
肝细胞生长因子受体激动剂多肽 |
2093305-05-4 |
详细
|
| Tomeglovir |
托美洛韦 |
233254-24-5 |
详细
|
| KG5 |
化合物KG5 |
877874-85-6 |
详细
|
| AMG-337 |
AMG-337 |
1173699-31-4 |
详细
|
| Maribavir |
苯并咪唑核苷 |
176161-24-3 |
详细
|
| Ensartinib dihydrochloride |
2137030-98-7 |
2137030-98-7 |
详细
|
| Tandutinib hydrochloride |
Tandutinib (hydrochloride) |
2438900-70-8 |
详细
|
| Ficlatuzumab |
Ficlatuzumab |
1174900-84-5 |
详细
|
| CP-447697 |
4-[(苯并[B]噻吩-3-基羰基)[2-(4-氯苯基)乙基]氨基]-N-(2,4-二氟苯基)-1-哌啶甲酰胺 |
1092847-21-6 |
详细
|
| Polmacoxib |
帕马考昔 |
301692-76-2 |
详细
|
| Tyrosine kinase inhibitor |
DCL000409(XL184) |
1021950-26-4 |
详细
|
| Merestinib dihydrochloride |
N-[3-氟-4-[[1-甲基-6-(1H-吡唑-4-基)-1H-吲唑-5-基]氧基]苯基]-1-(4-氟苯基)-1,2-二氢-6-甲基-2-氧代-3-吡啶甲酰胺二盐酸盐 |
1206801-37-7 |
详细
|
| Entacapone sodium salt |
1047659-02-8 |
1047659-02-8 |
详细
|
| Ningetinib |
宁格替尼 |
1394820-69-9 |
详细
|
| Naproxen etemesil |
(S)-2-(甲磺酰)乙基 2-(6-甲氧基萘-2-基)丙酯 |
385800-16-8 |
详细
|
| Pentagamavunon-1 |
Pentagamavunon-1 |
27060-70-4 |
详细
|
| Diclofenac-d4 (sodium) |
DICLOFENAC-D4 SODIUM SALT (PHENYL-D4-ACETIC) |
154523-54-3 |
详细
|
| AMY-101 TFA |
AMY-101 TFA |
1789738-04-0 |
详细
|
| Alminoprofen |
阿明洛芬 |
39718-89-3 |
详细
|
| NY2267 |
化合物NY2267 |
886053-73-2 |
详细
|
| Revaprazan hydrochloride |
盐酸瑞伐拉赞 |
178307-42-1 |
详细
|
| Isoxicam |
伊索昔康 |
34552-84-6 |
详细
|
| Compstatin |
COMPSTATIN |
206645-99-0 |
详细
|
| Certepetide |
NRP-1激活剂 |
2580154-02-3 |
详细
|
| Tivantinib |
(3R,4R)-3-(5,6-二氢-4H-吡咯并[3,2,1-IJ]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷-2,5-二酮 |
905854-02-6 |
详细
|
| Dovitinib lactate |
多韦替尼乳酸盐 |
692737-80-7 |
详细
|
| Opicapone |
奥匹卡朋 |
923287-50-7 |
详细
|
| c-Met inhibitor 1 |
3-[(2-甲基-2H-吲唑-5-基)硫基]-6-(1-甲基-1H-吡唑-4-基)-1,2,4-三唑并[4,3-B]哒嗪 |
1357072-61-7 |
详细
|
| Danicopan |
Danicopan |
1903768-17-1 |
详细
|
| Ocarocoxib |
|
215122-22-8 |
详细
|
| Enflicoxib |
化合物 T27233 |
251442-94-1 |
详细
|
| Flurbiprofen axetil |
氟比洛芬酯 |
91503-79-6 |
详细
|
| JPE-1375 |
JPE-1375 |
1254036-23-1 |
详细
|
| Capmatinib |
卡马替尼 |
1029712-80-8 |
详细
|
| Letermovir |
莱特莫韦 |
917389-32-3 |
详细
|
| Merestinib |
梅沙替尼 |
1206799-15-6 |
详细
|
| Phenylbutazone-13C12 |
苯基布洛芬-13C12 |
1325559-13-4 |
详细
|
| CEP-40783 |
CEP-40783 |
1437321-24-8 |
详细
|
| EIPA hydrochloride |
EIPA HYDROCHLORIDE |
1345839-28-2 |
详细
|
| FD-IN-1 |
FD-IN-1 |
1646682-14-5 |
详细
|
| Elzovantinib |
CSF1R-IN-2 |
2271119-26-5 |
详细
|
| DS-1205b free base |
化合物DS-1205 |
1855860-24-0 |
详细
|
| XL092 |
XL092 |
2367004-54-2 |
详细
|